| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 272.39B | 254.39B | 235.23B | 217.85B | 209.32B | 206.16B |
| Gross Profit | 237.39B | 222.76B | 205.62B | 191.74B | 181.07B | 177.33B |
| EBITDA | 67.35B | 57.20B | 51.94B | 45.44B | 38.82B | 16.74B |
| Net Income | 29.07B | 26.59B | 24.67B | 21.47B | 17.79B | 2.27B |
Balance Sheet | ||||||
| Total Assets | 1.21T | 1.05T | 1.00T | 961.95B | 920.03B | 901.07B |
| Cash, Cash Equivalents and Short-Term Investments | 56.15B | 49.25B | 64.56B | 52.43B | 39.72B | 41.19B |
| Total Debt | 776.60B | 636.48B | 594.36B | 583.06B | 527.16B | 484.58B |
| Total Liabilities | 971.11B | 806.71B | 749.87B | 715.39B | 657.98B | 610.37B |
| Stockholders Equity | 238.56B | 246.14B | 253.25B | 246.14B | 261.61B | 290.18B |
Cash Flow | ||||||
| Free Cash Flow | -22.30B | -17.59B | 23.21B | 7.02B | 2.99B | 11.82B |
| Operating Cash Flow | -4.72B | -4.48B | 38.00B | 16.72B | 11.52B | 22.19B |
| Investing Cash Flow | -12.31B | -13.66B | -18.27B | -22.38B | -13.76B | -16.24B |
| Financing Cash Flow | 5.58B | 2.84B | -7.88B | 18.26B | 770.00M | -5.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥657.22B | 7.04 | 9.13% | 2.79% | 20.96% | 22.58% | |
69 Neutral | ¥750.56B | 10.93 | 7.97% | 3.48% | 6.65% | -4.35% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥185.85B | 9.94 | ― | 4.42% | 2.13% | -25.62% | |
66 Neutral | ¥341.67B | 14.65 | 3.46% | 3.04% | 10.31% | -40.64% | |
61 Neutral | ¥559.48B | 21.83 | 11.30% | 3.66% | 8.02% | 19.35% | |
56 Neutral | ¥221.05B | 6.81 | 13.08% | 1.25% | 15.37% | 26.00% |